How I treat venous thrombosis in children.
作者信息
Manco-Johnson Marilyn J
机构信息
Mountain States Regional Hemophilia & Thrombosis Center, PO Box 6507, MS F416, Aurora, CO 80045-0507, USA.
出版信息
Blood. 2006 Jan 1;107(1):21-9. doi: 10.1182/blood-2004-11-4211. Epub 2005 Aug 11.
Abstract
摘要
相似文献
1
How I treat venous thrombosis in children.
Blood. 2006 Jan 1;107(1):21-9. doi: 10.1182/blood-2004-11-4211. Epub 2005 Aug 11.
2
Sulodexide for the extended treatment of venous thromboembolism.
Int Angiol. 2016 Dec;35(6):531-533. Epub 2016 Sep 28.
3
Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug.
Prescrire Int. 2015 Jun;24(161):150.
4
Novel oral anticoagulants in the treatment of cerebral venous thrombosis.
Int Angiol. 2016 Aug;35(4):365-8. Epub 2015 May 21.
5
Optimizing the duration of anticoagulation therapy for venous thrombosis.
CMAJ. 1999 May 4;160(9):1317-8.
6
Unprovoked deep vein thrombosis should be treated with long-term anticoagulation--no.
J Thromb Haemost. 2007 Dec;5(12):2336-9. doi: 10.1111/j.1538-7836.2007.02771.x. Epub 2007 Sep 24.
7
Long-term anticoagulation prophylaxis following acute thromboembolism.
Dis Mon. 2005 Feb-Mar;51(2-3):158-65. doi: 10.1016/j.disamonth.2005.03.011.
8
Anticoagulants in portal vein thrombosis: don't be so shy!
Blood. 2009 May 14;113(20):5031-2; author reply 5032. doi: 10.1182/blood-2009-02-202770.
9
Appropriateness of breast biopsy in rare cases of spontaneous breast hemorrhage resulting from anticoagulation therapy.
Breast J. 2005 Sep-Oct;11(5):363-4. doi: 10.1111/j.1075-122X.2005.00016.x.
10
[What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?].
Presse Med. 2000 Apr 8;29(13):766-8.
引用本文的文献
1
Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish.
Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2315083121. doi: 10.1073/pnas.2315083121. Epub 2024 Feb 26.
2
The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis.
Int J Mol Sci. 2023 Sep 8;24(18):13864. doi: 10.3390/ijms241813864.
3
Magnetically Powered Microwheel Thrombolysis of Occlusive Thrombi in Zebrafish.
bioRxiv. 2023 Sep 15:2023.09.11.557256. doi: 10.1101/2023.09.11.557256.
4
How I treat pediatric venous thromboembolism in the DOAC era.
Blood. 2024 Feb 1;143(5):389-403. doi: 10.1182/blood.2022018966.
5
Immune Responses to Some Viral Infections That Have a High Evolutionary Potential-A Case Report with Literature Review.
Life (Basel). 2022 Jun 23;12(7):940. doi: 10.3390/life12070940.
6
The Trilogy of SARS-CoV-2 in Pediatrics (Part 3): Thrombosis, Anticoagulant, and Antiplatelet Considerations.
J Pediatr Pharmacol Ther. 2021;26(6):565-576. doi: 10.5863/1551-6776-26.6.565. Epub 2021 Aug 16.
7
Venous Thromboembolism in Children: From Diagnosis to Management.
Int J Environ Res Public Health. 2020 Jul 11;17(14):4993. doi: 10.3390/ijerph17144993.
8
Long-term vascular access in differently resourced settings: a review of indications, devices, techniques, and complications.
Pediatr Surg Int. 2020 May;36(5):551-562. doi: 10.1007/s00383-020-04640-0. Epub 2020 Mar 21.
9
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
10
Management of venous thrombosis in the pediatric patient.
Pediatric Health Med Ther. 2015 Jul 21;6:111-119. doi: 10.2147/PHMT.S65697. eCollection 2015.
本文引用的文献
1
Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis.
Am Heart J. 2005 Jan;149(1 Suppl):S19-31. doi: 10.1016/j.ahj.2004.10.019.
2
Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study.
J Vasc Surg. 2004 Nov;40(5):965-70. doi: 10.1016/j.jvs.2004.08.025.
3
C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis.
J Vasc Surg. 2004 Oct;40(4):644-9. doi: 10.1016/j.jvs.2004.07.004.
4
Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep;126(3 Suppl):645S-687S. doi: 10.1378/chest.126.3_suppl.645S.
5
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep;126(3 Suppl):188S-203S. doi: 10.1378/chest.126.3_suppl.188S.
6
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
N Engl J Med. 2004 Sep 9;351(11):1081-8. doi: 10.1056/NEJMoa040161.
7
Invasive approaches to treatment of venous thromboembolism.
Circulation. 2004 Aug 31;110(9 Suppl 1):I27-34. doi: 10.1161/01.CIR.0000140900.64198.f4.
8
Clinical and laboratory diagnosis of deep vein thrombosis: new cost-effective strategies.
Semin Vasc Med. 2001;1(1):39-42. doi: 10.1055/s-2001-14540.
9
Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes.
Intensive Care Med. 2004 Aug;30(8):1615-24. doi: 10.1007/s00134-004-2315-4. Epub 2004 May 19.
10
Laboratory markers in the diagnosis of venous thromboembolism.
Circulation. 2004 Mar 30;109(12 Suppl 1):I4-8. doi: 10.1161/01.CIR.0000122869.59485.36.
Zotero 插件